Cargando…
Commentary: Treatment Outcome of Different Chemotherapy in Patients With Relapsed or Metastatic Malignant Urachal Tumor
Autores principales: | Szarvas, Tibor, Reis, Henning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189274/ https://www.ncbi.nlm.nih.gov/pubmed/35707349 http://dx.doi.org/10.3389/fonc.2022.864708 |
Ejemplares similares
-
Treatment Outcome of Different Chemotherapy in Patients With Relapsed or Metastatic Malignant Urachal Tumor
por: Chen, Meiting, et al.
Publicado: (2021) -
Metastatic Urachal Carcinoma Treated With Several Different Combined Regimens: A Case Report
por: Zheng, Han, et al.
Publicado: (2021) -
Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data
por: Reis, Henning, et al.
Publicado: (2018) -
A rare case of urachal inflammatory myofibroblastic tumor
por: George, Rose, et al.
Publicado: (2021) -
Urachal adenocarcinoma surgical management – Emphasis on enbloc umbilectomy and urachal remnant excision with negative margins
por: Althaf, Syed, et al.
Publicado: (2019)